Alemtuzumab is used for the treatment of B-cell chronic lymphocytic leukemia in people who have been treated with alkylating agents and who have failed fludarabine therapy.

Apr 8, 2025 · Alemtuzumab may cause a brain infection that can lead to disability or death. Tell your doctor if you have problems with speech, thought, vision, or muscle movement. These …

This page contains brief information about alemtuzumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

Aug 1, 2025 · Alemtuzumab injection is used to treat the relapsing forms of multiple sclerosis (MS), including relapsing-remitting disease and active secondary progressive disease. This …

Alemtuzumab is a monoclonal anti-CD52 antibody used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis.

Alemtuzumab injection is used to treat B-cell chronic lymphocytic leukemia (B-CLL; a slowly developing cancer in which too many of a certain type of white blood cell accumulate in the …

Dec 12, 2022 · Alemtuzumab Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side …

Aug 7, 2025 · Alemtuzumab (Campath®) is a CD52 cytolytic antibody therapy used in the treatment of B-cell chronic lymphocytic leukemia (B-CLL).

What is this medication? ALEMTUZUMAB (AL em TOOZ oo mab) treats leukemia. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the …

Apr 11, 2025 · Alemtuzumab is a humanized recombinant monoclonal antibody that specifically targets the CD52 antigen, which is expressed on both malignant and normal T and B …